Effects of Relugolix-CT on Uterine Fibroid (UF) and Uterine Volume through 52 Weeks: Liberty Long-Term Extension (LTE) Post Hoc Analysis

Evaluate baseline UF and uterine volume impact on outcomes with relugolix combination therapy (Relugolix-CT) in women with UF-associated heavy menstrual bleeding (HMB) in the LIBERTY LTE study.

Source: The Journal of Minimally Invasive Gynecology - October 27, 2023 Category: OBGYN Authors: A Al-Hendy, R Venturella, A Lukes, R McLean, D Zhai Tags: ORAL SESSION 02 - Fibroids Source Type: research